mCRPC: Challenges and opportunities in a booming area

Managing mCRPC in daily practice: a pragmatic approach

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer

Improving outcomes in chronic lymphocytic leukaemia

Translational studies of CDK and PARP inhibitors

New therapy aspects for myeloid chronic lymphoma

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma

Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL)

Comment: Transplantation and short telomeres increase the risk of cognitive impairment

New agents in CLL

Chronic lymphocytic leukaemia: A new treatment era is born